Author:
Zhang Chuankai,Jiang Songsong,Wang Jun,Wu Xianning,Ke Li
Abstract
Abstract
Background
The new-onset postoperative atrial fibrillation (NOPAF) following pulmonary resection is a common clinical concern. The aim of this study was to construct a nomogram to intuitively predict the risk of NOPAF and offered protective treatments.
Methods
Patients who underwent pulmonary resection between January 2018 and December 2020 were consecutively enrolled. Forward stepwise multivariable logistic regression analyses were used to screen independent predictors, and a derived nomogram model was built. The model performance was evaluated in terms of calibration, discrimination and clinical utility and validated with bootstrap resampling.
Results
A total of 3583 patients who met the research criteria were recruited for this study. The incidence of NOPAF was 1.507% (54/3583). A nomogram, composed of five independent predictors, namely age, admission heart rate, extent of resection, laterality, percent maximum ventilation volume per minute (%MVV), was constructed. The concordance index (C-index) was 0.811. The nomogram showed substantial discriminative ability, with an area under the receiver operating characteristic curve of 0.811 (95% CI 0.758-0.864). Moreover, the model shows prominent calibration performance and higher net clinical benefits.
Conclusion
We developed a novel nomogram that can predict the risk of NOPAF following pulmonary resection, which may assist clinicians predict the individual probability of NOPAF and perform available prophylaxis. By using bootstrap resampling for validation, the optimal discrimination and calibration were demonstrated, indicating that the nomogram may have clinical practicality.
Funder
Natural Science Foundation of Anhui Province
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Fan K, Chen L, Liu F, Ding X, Yan P, Gao M, Yu W, Liu H, Yu Y. Predicting New-Onset Postoperative Atrial Fibrillation Following Isolated Coronary Artery Bypass Grafting: Development and Validation of a Novel Nomogram. Int J Gen Med. 2022;15:937–48.
2. Bidar E, Bramer S, Maesen B, Maessen JG, Schotten U. Post-operative Atrial Fibrillation - Pathophysiology, Treatment and Prevention. J Atr Fibrillation. 2013;5(6):781.
3. Roselli EE, Murthy SC, Rice TW, Houghtaling PL, Pierce CD, Karchmer DP, Blackstone EH. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg. 2005;130(2):438–44.
4. Amar D, Zhang H, Chung MK, Tan KS, Desiderio D, Park BJ, Pedoto A, Roistacher N, Isbell JM, Molena D, et al. Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind. Randomized Trial Anesthesiol. 2022;136(6):916–26.
5. Siontis KC, Gersh BJ, Weston SA, Jiang R, Kashou AH, Roger VL, Noseworthy PA, Chamberlain AM. Association of new-onset atrial fibrillation after Noncardiac surgery with subsequent stroke and transient ischemic attack. Jama. 2020;324(9):871–8.